Dysentery is a type disease related to gastroenteritis that results in bloody diarrhea. Fever, abdominal pain, and feeling of incomplete defections are different types of symptoms occur during dysentery. This disease is generally caused due to the bacterial infection named as Shigella and also known as Shigellosis. Moreover, other causes include certain chemicals, other bacteria, protozoa, and parasitic worms. Dysentery can be managed by maintaining fluid levels in the body by using oral rehydration solution therapy. Anti-amoebicidal drugs, anti-parasitic, and antibiotics are administered during the treatment of dysentery.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the dysentery drugs market.
Top Impacting Factors
- Increase in cases of bacterial infections, rise in unhygienic practises, rise in awareness regarding diarrhoea treatments, surge in demand for minimally invasive treatment procedures, low water filtration procedures in rural areas, and increase in cases of dysentery across the globe can drive the growth of market.
- In addition, increase in adoption of advance treatment procedures, rise in usage of targeted infection treatment procedures, R & D activities to improve quality of drugs, launch of novel dysentery treatment drugs, strategic developments by key market players such as agreements & joint ventures, and rise in awareness regarding use of anti-biotic for treatment of dysentery are the key factors that drive the growth of dysentery drugs market.
- However, adverse effects related use of these drugs can restrain growth of market.
- Contrarily, low cost of treatment and government initiatives in spreading awareness regarding dysentery symptoms & treatments are expected to offer lucrative opportunities for the expansion of the market.
Market Trends
New Product Launches to Flourish the Market
In 2020, huvepharma announced approval of FDA for launch of product Vetmulin. It is a liquid antibiotic which can be used in treatment of swine dysentery.
In 2019, Fresenius Kabi announced launch of Ertapenem for Injection in a 1 gram vial. This drug used in treatment of abdominal infections, urinary tract infections and dysentery conditions.
Key Benefits of the Report
- This study presents the analytical depiction of dysentery drugs market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Dysentery Drugs Market Report
- Which are the leading players active in the dysentery drugs market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "dysentery drugs"?
- What is "dysentery drugs" market prediction in the future?
- Who are the leading global players in the "dysentery drugs" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "dysentery drugs" market report?
Dysentery Drugs Market Report Highlights
| Aspects | Details |
 By Drug Type |
|
 By Drug Class |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Aurobindo Pharma, Dr. Reddys Laboratories, Glenmark Pharmaceuticals, Mylan Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Lupin Pharmaceuticals, Cipla Limited, Sun Pharmaceutical Limited, Proctor & Gamble Pharmaceuticals, Teva Pharmaceuticals |
Loading Table Of Content...
